• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆生长激素(GH)结合蛋白:对GH与受体结合及GH作用的影响。

Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action.

作者信息

Mannor D A, Winer L M, Shaw M A, Baumann G

机构信息

Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

J Clin Endocrinol Metab. 1991 Jul;73(1):30-4. doi: 10.1210/jcem-73-1-30.

DOI:10.1210/jcem-73-1-30
PMID:2045472
Abstract

GH-binding proteins (GH-BP) have recently been discovered in human plasma, but their biological function is unknown. The high affinity GH-BP is related to the GH receptor and may modulate the interaction of GH with tissue receptors, whereas the low affinity GH-BP should be inert in this regard. Modulation of receptor binding probably results in modulation of GH bioactivity. To address these issues, we examined the effects of purified GH-BPs as well as whole plasma on GH binding to receptors in human, rabbit, and female rat liver and in rat adipocytes. High affinity BP inhibited binding of GH to receptors in a dose-dependent fashion. Substantial inhibition was observed within the physiological range of BP concentrations; human liver and rat adipocytes were the most sensitive in this regard. In contrast, the low affinity BP had no effect on receptor binding of GH. Whole human plasma also inhibited GH binding to receptors. This effect could be attributed to its content of GH-BP, since removal or primary absence of the BP from plasma abolished its inhibitory effect. Purified high affinity BP also inhibited GH-dependent insulin-like growth factor-I production by cultured human fibroblasts to a degree comparable to receptor inhibition. We conclude that the circulating high affinity GH-BP, by sequestering GH, substantially interferes with binding of GH to its receptor, and that the well known inhibitory effect of plasma in RRAs for GH is largely due to this BP. GH action in human fibroblasts in vitro is similarly inhibited by this BP.

摘要

生长激素结合蛋白(GH-BP)最近在人血浆中被发现,但其生物学功能尚不清楚。高亲和力GH-BP与生长激素受体相关,可能调节生长激素与组织受体的相互作用,而低亲和力GH-BP在这方面可能是无活性的。受体结合的调节可能导致生长激素生物活性的调节。为了解决这些问题,我们研究了纯化的GH-BP以及全血浆对生长激素与人、兔和雌性大鼠肝脏及大鼠脂肪细胞中受体结合的影响。高亲和力BP以剂量依赖性方式抑制生长激素与受体的结合。在BP浓度的生理范围内观察到了显著的抑制作用;在这方面,人肝脏和大鼠脂肪细胞最为敏感。相比之下,低亲和力BP对生长激素的受体结合没有影响。人全血浆也抑制生长激素与受体的结合。这种作用可归因于其GH-BP的含量,因为从血浆中去除或原本不存在BP会消除其抑制作用。纯化的高亲和力BP也在一定程度上抑制培养的人成纤维细胞中生长激素依赖的胰岛素样生长因子-I的产生,其程度与受体抑制相当。我们得出结论,循环中的高亲和力GH-BP通过螯合生长激素,极大地干扰了生长激素与其受体的结合,并且血浆在生长激素放射受体分析中众所周知的抑制作用很大程度上归因于这种BP。这种BP同样抑制体外培养的人成纤维细胞中的生长激素作用。

相似文献

1
Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action.血浆生长激素(GH)结合蛋白:对GH与受体结合及GH作用的影响。
J Clin Endocrinol Metab. 1991 Jul;73(1):30-4. doi: 10.1210/jcem-73-1-30.
2
Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH-receptors, and circulating GH-binding protein and insulin-like growth factor-I.
Endocrinology. 1992 Jul;131(1):423-9. doi: 10.1210/endo.131.1.1612023.
3
The interrelationship of growth hormone (GH), liver membrane GH receptor, serum GH-binding protein activity, and insulin-like growth factor I in the male rat.雄性大鼠中生长激素(GH)、肝细胞膜GH受体、血清GH结合蛋白活性及胰岛素样生长因子I的相互关系
Endocrinology. 1990 Apr;126(4):1914-20. doi: 10.1210/endo-126-4-1914.
4
Binding of intact and cleaved human growth hormone to hepatic receptors and plasma binding proteins.完整及裂解的人生长激素与肝脏受体及血浆结合蛋白的结合
Endocrinology. 1992 May;130(5):3085-91. doi: 10.1210/endo.130.5.1533365.
5
Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.人生长激素片段1 - 43和44 - 191:人和非灵长类系统中的体外促生长活性及受体结合特性
Endocrinology. 1996 Jan;137(1):90-5. doi: 10.1210/endo.137.1.8536647.
6
Growth hormone-binding proteins in plasma.血浆中的生长激素结合蛋白
Nutrition. 1993 Nov-Dec;9(6):546-53.
7
Growth hormone (GH)-binding proteins in GH-resistant guinea pigs.生长激素抵抗型豚鼠中的生长激素(GH)结合蛋白
Growth Regul. 1996 Sep;6(3):165-75.
8
The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors.人血浆中生长激素结合蛋白复合物的化学计量学:与细胞表面受体的比较。
J Clin Endocrinol Metab. 1994 May;78(5):1113-8. doi: 10.1210/jcem.78.5.8175967.
9
The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells.从人IM-9淋巴细胞克隆出的生长激素(GH)结合蛋白可调节22千道尔顿和20千道尔顿的人GH对IM-9淋巴细胞中GH受体的下调作用以及该激素对Nb2淋巴瘤细胞的生物学效应。
Endocrinology. 1993 Dec;133(6):2809-17. doi: 10.1210/endo.133.6.8243308.
10
Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.生长激素(GH)对大鼠肝脏中胰岛素样生长因子I和GH受体/结合蛋白基因表达的差异调节
Endocrinology. 1992 Jun;130(6):3257-64. doi: 10.1210/endo.130.6.1375898.

引用本文的文献

1
Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors.生长激素蛋白质组图谱的创建旨在促进垂体神经内分泌肿瘤整体管理中的预测、预防和个性化方法。
EPMA J. 2023 Jun 27;14(3):443-456. doi: 10.1007/s13167-023-00329-1. eCollection 2023 Sep.
2
Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.生长激素与糖尿病发病机制中的代偿调节
Curr Diab Rep. 2022 Oct;22(10):511-524. doi: 10.1007/s11892-022-01488-7. Epub 2022 Aug 24.
3
TIMP3 Modulates GHR Abundance and GH Sensitivity.
组织金属蛋白酶抑制剂3调节生长激素受体丰度和生长激素敏感性。
Mol Endocrinol. 2016 Jun;30(6):587-99. doi: 10.1210/me.2015-1302. Epub 2016 Apr 13.
4
Liver-derived IGF-I contributes to GH-dependent increases in lean mass and bone mineral density in mice with comparable levels of circulating GH.在循环生长激素水平相当的小鼠中,肝脏来源的胰岛素样生长因子-I有助于生长激素依赖性的瘦体重和骨矿物质密度增加。
Mol Endocrinol. 2011 Jul;25(7):1223-30. doi: 10.1210/me.2011-0047. Epub 2011 Apr 28.
5
Growth hormone receptor synthesis and release in tumorous somatolactotrophs.肿瘤性生长激素催乳素细胞中生长激素受体的合成与释放
Endocrine. 1995 Jun;3(6):461-7. doi: 10.1007/BF02935653.
6
Insulin-Like growth factor I: implications in aging.胰岛素样生长因子I:对衰老的影响
Drugs Aging. 2000 Jan;16(1):29-40. doi: 10.2165/00002512-200016010-00003.
7
Binding and signalling properties of a growth hormone enhancing monoclonal antibody.一种生长激素增强单克隆抗体的结合与信号传导特性
Mol Cell Biochem. 1999 Aug;198(1-2):61-7. doi: 10.1023/a:1006989232646.
8
The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.雌激素替代疗法的给药途径对绝经后女性的底物氧化和身体组成具有不同的影响。
J Clin Invest. 1998 Sep 1;102(5):1035-40. doi: 10.1172/JCI2773.
9
Growth hormone. A paracrine growth factor?生长激素。一种旁分泌生长因子?
Endocrine. 1997 Dec;7(3):267-79. doi: 10.1007/BF02801319.
10
Growth hormone binding protein and free growth hormone in chronic renal failure.
Pediatr Nephrol. 1996 Jun;10(3):328-30. doi: 10.1007/BF00866772.